BBH vs. SCHD
BBH (VanEck Vectors Biotech ETF) and SCHD (Schwab U.S. Dividend Equity ETF) are both exchange-traded funds - BBH is a Health & Biotech Equities fund tracking the MVIS US Listed Biotech 25 Index, while SCHD is a Dividend fund tracking the Dow Jones U.S. Dividend 100 Index. Both are passively managed. Over the past 10 years, BBH returned 5.75%/yr vs 12.77%/yr for SCHD. A 0.53 correlation means they provide meaningful diversification when combined. BBH charges 0.35%/yr vs 0.06%/yr for SCHD.
Performance
BBH vs. SCHD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBH achieves a -1.85% return, which is significantly lower than SCHD's 19.01% return. Over the past 10 years, BBH has underperformed SCHD with an annualized return of 5.75%, while SCHD has yielded a comparatively higher 12.77% annualized return.
BBH
- 1D
- 2.22%
- 1M
- 0.09%
- YTD
- -1.85%
- 6M
- -5.32%
- 1Y
- 23.92%
- 3Y*
- 6.14%
- 5Y*
- 0.31%
- 10Y*
- 5.75%
SCHD
- 1D
- 0.00%
- 1M
- 2.70%
- YTD
- 19.01%
- 6M
- 18.63%
- 1Y
- 27.16%
- 3Y*
- 15.09%
- 5Y*
- 8.36%
- 10Y*
- 12.77%
BBH vs. SCHD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | -1.85% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
SCHD Schwab U.S. Dividend Equity ETF | 19.01% | 4.34% | 11.66% | 4.54% | -3.26% | 29.87% | 15.03% | 27.29% | -5.56% | 20.85% |
Correlation
The correlation between BBH and SCHD is 0.48, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.48 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.57 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.55 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.50 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2011 | 0.53 |
The correlation between BBH and SCHD has been stable across timeframes, ranging from 0.48 to 0.57 - a consistent structural relationship.
BBH vs. SCHD - Sectors Allocation Comparison
Sectors
BBH
SCHD
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
BBH
SCHD
Basic Materials
BBH
-
SCHD
Communication Services
BBH
-
SCHD
Consumer Cyclical
BBH
-
SCHD
Consumer Defensive
BBH
-
SCHD
Energy
BBH
-
SCHD
Financial Services
BBH
-
SCHD
Industrials
BBH
-
SCHD
Real Estate
BBH
-
SCHD
-
Technology
BBH
-
SCHD
Utilities
BBH
-
SCHD
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBH vs. SCHD — Risk / Return Rank
BBH
SCHD
BBH vs. SCHD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBH | SCHD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.23 | ||
| Sortino ratioReturn per unit of downside risk | -1.98 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.45 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 2.28 | 5.91 | -3.63 |
| Martin ratioReturn relative to average drawdown | 5.81 | 14.53 | -8.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBH | SCHD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.26 | 2.49 | -1.23 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.01 | 0.58 | -0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.26 | 0.77 | -0.51 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.86 | -0.48 |
Drawdowns
BBH vs. SCHD - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.70%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for BBH and SCHD.
Loading charts...
Drawdown Indicators
| BBH | SCHD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.70% | -33.37% | -39.33% |
Max Drawdown (1Y)Largest decline over 1 year | -10.55% | -4.61% | -5.94% |
Max Drawdown (3Y)Largest decline over 3 years | -22.74% | -16.13% | -6.61% |
Max Drawdown (5Y)Largest decline over 5 years | -39.86% | -16.85% | -23.01% |
Max Drawdown (10Y)Largest decline over 10 years | -39.86% | -33.37% | -6.49% |
Current DrawdownCurrent decline from peak | -13.81% | -1.40% | -12.41% |
Average DrawdownAverage peak-to-trough decline | -20.75% | -3.32% | -17.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.13% | 1.88% | +2.25% |
Volatility
BBH vs. SCHD - Volatility Comparison
VanEck Vectors Biotech ETF (BBH) has a higher volatility of 6.06% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 2.66%. This indicates that BBH's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBH | SCHD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.06% | 2.66% | +3.40% |
Volatility (6M)Calculated over the trailing 6-month period | 14.28% | 7.66% | +6.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.02% | 10.96% | +8.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.50% | 14.38% | +7.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.17% | 16.72% | +5.45% |
BBH vs. SCHD - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is higher than SCHD's 0.06% expense ratio.
Dividends
BBH vs. SCHD - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.51%, less than SCHD's 3.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
SCHD Schwab U.S. Dividend Equity ETF | 3.26% | 3.82% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% |
Frequently Asked Questions
BBH and SCHD have a correlation of 0.48, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBH has higher volatility (6.06%) compared to SCHD (2.66%). In terms of maximum drawdown, BBH dropped -72.70% vs SCHD's -33.37%.
On 10-year performance, SCHD leads with 12.77% vs 5.75% for BBH. On fees, SCHD is cheaper at 0.06% per year. On volatility, SCHD has been the lower-risk option at 2.66%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SCHD has performed better with a 12.77% return vs 5.75%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SCHD is cheaper with a 0.06% expense ratio, compared with 0.35% for BBH.
SCHD has the higher dividend yield at 3.26%, compared with 0.51% for BBH.
BBH is categorized as Health & Biotech Equities, while SCHD is Dividend. BBH tracks MVIS US Listed Biotech 25 Index, while SCHD tracks Dow Jones U.S. Dividend 100 Index. They also come from different issuers: VanEck and Charles Schwab. Their fees differ too: 0.35% for BBH and 0.06% for SCHD.
SCHD currently has the higher Sharpe Ratio (2.49 vs 1.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBH and SCHD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer